Skip to main content
logo
Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
10.54
-0.38 (-3.44%)
At close: Aug 24, 2026, 4:00 PM EDT
10.54
0.00 (0.00%)
After-hours: Aug 24, 2026, 4:10 PM EDT

Lexaria Bioscience Cash Flow Statement

Millions USD. Fiscal year is Sep - Aug.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Net Income
-7.73-11.9-5.8-6.66-7.27-4.03
Depreciation & Amortization
0.110.120.110.190.140.15
Asset Writedown & Restructuring Costs
0.210.250.060.11--
Loss (Gain) From Sale of Investments
0.030.030.070.220.760.17
Stock-Based Compensation
0.370.860.490.171.951.28
Provision & Write-off of Bad Debts
--0.01--0.05
Other Operating Activities
-0-0-0.01-0.05-0.12-0.15
Change in Accounts Receivable
0.31-0.21-0.040.03-0.140.19
Change in Inventory
---0.04-00.1
Change in Accounts Payable
-1.110.40.830.090.050.01
Change in Unearned Revenue
0-00---0.04
Change in Other Net Operating Assets
0.390.02-0.69-0.01-0.26-0.19
Operating Cash Flow
-7.43-10.45-4.96-5.88-4.88-3.99
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Capital Expenditures
-0.04-0.02-0.04-0.03-0.05-
Sale of Property, Plant & Equipment
-----0.27
Sale (Purchase) of Intangibles
-0.06-0.08-0.15-0.14-0.13-0.08
Investment in Securities
-0.14-0.14----
Investing Cash Flow
-0.24-0.24-0.19-0.17-0.180.19

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Long-Term Debt Repaid
-----0.04-0.07
Net Debt Issued (Repaid)
-----0.04-0.07
Issuance of Common Stock
6.526.0510.321.59-13.49
Financing Cash Flow
6.526.0510.321.59-0.0413.42

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Foreign Exchange Rate Adjustments
0.03-0.05-0.02---
Net Cash Flow
-1.12-4.75.15-4.46-5.19.62

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Free Cash Flow
-7.47-10.48-5-5.91-4.93-3.99
Free Cash Flow Growth
------
Free Cash Flow Margin
-3848.61%-1483.88%-1077.38%-2614.84%-1929.75%-552.02%
Free Cash Flow Per Share
-4.97-8.73-6.06-13.41-12.56-13.63
Levered Free Cash Flow
-4.69-6.16-2.98-3.6-2.3-2.37
Unlevered Free Cash Flow
-4.69-6.16-2.98-3.6-2.3-2.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Cash Income Tax Paid
0--0.01-0-0.02
Change in Working Capital
-0.410.20.110.14-0.350.06
SEC Filings: 10-K · 10-Q